Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-14

Clinical Trial Update: Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)? [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial from Drexel University is evaluating whether treating mitochondrial dysfunction can affect autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Drexel University | Conditions: Autism Spectrum Disorders, Mitochondrial Diseases | Phase 1 | Status: UNKNOWN